Scott Samuel is a strategic and entrepreneurial leader with a multi-disciplinary set of skills, including but not limited to strategic direction; governance; enhancing enterprise value; M&A; corporate finance; tax; capital raising;
and succession. Developing and keeping strong relationships with all stakeholder constituencies has been a focal point of Scott’s career.
Professionally diverse; senior management backgrounds in technology, life science and consulting with profitable exits of two technology companies in 8 years.
Scott and Skura founders drove the successful sale and spin off of Skura Corp in 2008 with the sale of the consulting arm (75 employees) to IMS Health (now IQVIA – IQV (NYSE)).
Scott and Skura founders then built up the software spin out (of IMS Health exit) and Scott sold that to Indegene, Inc., a global health solutions company in 2016.